Minoryx appoints Didier Le Normand as group CFO and general manager of its Belgian subsidiary

by Gemma Escarré,

Minoryx Therapeutics has appointed Didier Le Normand as group Chief Financial Officer (CFO) as well as general manager of its recently opened Belgian subsidiary.

Le Normand started his career in banking in the US and France and then established a long international career in finance and operations as well as M&A transactions for private and listed companies, particularly in the healthcare and technology sectors. He was CFO at STAT-DX, a Catalan diagnostics company solded to Qiagen in 2018.

More information

Photo: Didier Le Normand - © Minoryx Therapeutics


To comment, please login or create an account